Globela Pharma Private Limited
Indian Pharmaceutical Exporter · Antifungals Specialist · $3.3M Total Trade · DGFT Verified
Globela Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $3.3M across 9 products in 5 therapeutic categories. Based on 139 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Fluconazole ($1.5M), Erythromycin ($750.0K), Febuxostat ($565.3K).
Globela Pharma Private Limited — Export Portfolio & Destination Treemap

Who is Globela Pharma Private Limited? — Company Overview & Market Position
Globela Pharma Private Limited, established on February 8, 2006, is a privately held pharmaceutical manufacturing company headquartered in Surat, Gujarat, India. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, catering to both domestic and international markets. Globela Pharma is registered under the Corporate Identification Number (CIN) U24230GJ2006PTC047699.
The company's authorized capital stands at ₹68.5 crore, with a paid-up capital of ₹56.92 crore, reflecting a strong financial foundation. Globela Pharma operates with a dedicated workforce of approximately 201 to 500 employees, as indicated on their LinkedIn profile. Their official website, www.globelapharma.com, provides comprehensive information about their products, services, and global presence.